- 2,329
- Michigan
- FuriousDemon
Hope your cousin is doing well now.Yeah the way the UK government has decided to open up is concerning for me.
Most of my family is still in the UK and a cousin spent 4.5 months with the first two weeks on life support in a Glasgow hospital with Covid. At the time there was a bit of a lull in cases so the hospital's weren't at capacity.
Hopefully for the country it doesn't get there and the rate of vaccinated people helps keep the severe cases down.
Since it seems like you may know a bit more than others, I got a question I wanted to ask:It's hard to say because from my brief understanding it sounds like Pfizer is basing the whole thing off of a single set of data from Israel that says immunity goes from about 90% to 64%. While I'm sure the Israeli data is good, it only represents a very small percentage of somewhat genetically similar people.
I think a booster is needed eventually, but this seems pretty early and is going to pose a huge challenge for countries like the US. I mean we're not even at the year mark yet from when people outside the testing cohort received their first dose. However, since so many people are unwilling to get vaccinated, maybe the best strategy is to continue to boost the immunity of those who are willing to be vaccinated.
I haven't seen anything from Moderna either. It'll be interesting to see what their plan is going forward. If it's just the Pfizer one that requires three doses that's really going to make for a good old cluster.
Why is it that most data and studies are focused on Pfizer and not Moderna? I kind of assume that Pfizer data applies to Moderna as well since they both are mRNA but it is a bit puzzling.